NPAS2 dampens chemo-sensitivity of lung adenocarcinoma cells by enhancing DNA damage repair
Abstract Chemotherapeutic agents, including cisplatin, have remained a cornerstone of lung adenocarcinoma (LUAD) treatment and continue to play an essential role in clinical practice, despite remarkable progress in therapeutic strategies. Hence, a thorough comprehension of the molecular mechanisms u...
Main Authors: | Youyu Zhang, Yuqiao Chen, Wentao Huang, Yuan Zhou, Ya Wang, Kai Fu, Wei Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06256-3 |
Similar Items
-
Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
by: Yongbiao Huang, et al.
Published: (2023-04-01) -
NPAs in India's banks: trends and determinants
by: Santosh Kumar Das
Published: (2023-12-01) -
BANKS’ PROFITABILITY AND NPAs: AN EMPIRICAL STUDY
by: Ms. Astha Dewan, et al.
Published: (2016-07-01) -
Npas4: Linking Neuronal Activity to Memory
by: Sun, Xiaochen, et al.
Published: (2017) -
Structural insights and characterization of human Npas4 protein
by: Ammad Fahim, et al.
Published: (2018-06-01)